Skip to content

NON RANDAMISED CLINICAL STUDY OF SIDDHA MEDICINE PERUNGAYA CHOORANAM FOR ACID REFLUX DISEASE

PHASE II NON-RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE PERUNGAYA CHOORNAM FOR VAYU GUNMAM (GASTROESOPHAGEAL REFLUX DISEASE)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047439
Enrollment
40
Registered
2022-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

Intervention1: Perungaya chooranam 1 gram BD in hotwater 48 days: Its a siddha herbo mineral preparation Intervention2: Perungaya chooranam: it s a siddha poly herbo mineral preparation pharmacologica

Sponsors

MAGUDAPATHI S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 18 -60 all gender 2 Epigastric burning 3 Sign of acid reflux 4 Indigestion 5 Abdominal pain 6 Nausea 7 Abdominal bloating 8 H/o NSAID administration 9 FSSG SCALE FOR GERD SCORE

Exclusion criteria

Exclusion criteria: 1 Pregnancy & lactation 2 CA of stomach 3 Barrett esophagus 4 acute pancreatitis 5 Cholelithiasis 6 Pyloric stenosis 7 Gastric perforation 8 H/o Corticosteroid drug

Design outcomes

Primary

MeasureTime frame
Reduction of epigastric burning vomiting nausea cough dysphagia abdominal bloating Any one or more of the above results will be considered as primary outcome over the course of 3 or 4 weeks using FSSG GERD SCALETimepoint: The primary outcome will be assessed after a period of 48 days

Secondary

MeasureTime frame
The safety and efficacy of the drug will be assessed during the course of the studyTimepoint: The safety and efficacy will be assessed in a time period of 48 days

Countries

India

Contacts

Public ContactS Magudapathi

GOVT SIDDHA MEDICAL COLLEGE CHENNAI

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026